ZADA PHARMACEUTICALS FROM LUKAVAC OPENS AFRICA MARKET – FIRST MEDICINE CONTAINERS PLACED IN SOMALIA

LUKAVAC, JUNE 19 (ONASA) – ZADA Pharmaceuticals d.o.o., one of the leading Bosnian-Herzegovinian drug manufacturers with 100% domestic ownership, recently opened the African market for its high-quality products from the pharmaceutical industry.
The first quantities of products have already been placed in Somalia, and soon a new contingent of medicines and food supplements will be delivered, intended for hospitals and pharmacies there.
These are all 150 products with the ZADA Pharmaceuticals brand – prescription drugs, over-the-counter drugs, and nutritional supplements.
“We waited until after the export of the first container of medicines, we received feedback on user satisfaction and the effectiveness of our products. Given that a new delivery of the entire assortment is coming soon and in a very short time, it is clear that the reactions are extremely positive. Exporting to Somalia we have opened the African market, as one of the fastest growing in the world, and we hope that this will be the beginning of a successful story not only for us, but also for the Bosnian pharmaceutical industry as a whole. our African partners, that all our medicines and nutritional supplements, i.e. everything that ZADA produces, are of the same quality, whether they are intended for the domestic, EU, Asian or African market. After all, this is guaranteed by the EU GMP quality control standard, in addition to our corporate ethics , as the highest in the pharmaceutical industry, and only rare manufacturers can boast of owning it, said Esad Zahirović, a member of the Management Board of ZADA Pharmaceuticals d.o.o..
Zahirović also said that the company continues to expand both domestically and especially on foreign markets, and that new generic drugs and food supplements are in the final stages of implementation.
“After recently finding a partner for the markets of Uzbekistan, Azerbaijan and Georgia in Asia, Somalia is the fourth new market for this company this year. The company’s export expansion strategy in the time ahead will be focused on the EU market and the rest of the Middle East countries, he explains. Zahirovic.
ZADA Pharmaceuticals d.o.o. is one of the leading Bosnian manufacturers of medicines with 100% domestic ownership and an annual production capacity of 3 billion tablets and 300 million capsules for about 150 generic medicines.
Everything that ZADA produces is the result of its own knowledge and work within the projects carried out by the Research and Development department. Investing in research and development has positioned the ZADA company as a pharmaceutical industry recognized for its own formulations and technological approaches for the production of generic drugs with added values.
ZADA Pharmaceuticals is in possession of the highest standard for drug production – the EU GMP standard, which enables export to EU countries and the world.
ZADA became particularly well-known to the world and domestic public when, during the corona virus pandemic, it marketed the drug Malcovir, a generic drug that proved to be effective in the treatment of patients suffering from the coronavirus.
The company currently employs 150 pharmacists, technologists, doctors, engineers, and other personnel, with an average age of 35 years.
In addition to the valid EU guidelines of Good Manufacturing Practice (EU GMP) and the EN ISO 9001 standard, quality is also ensured by internal standards in accordance with the ZADA Pharmaceuticals Quality Regulations.